Magnolia Medical Technologies is a medical device company that develops and manufactures products to improve the accuracy and reliability of diagnostic tests. The company's flagship product, the Steripath Gen2 Initial Specimen Diversion Device, is designed to reduce the rate of blood culture contamination, a common problem in healthcare that can lead to misdiagnosis and inappropriate treatment. Magnolia Medical Technologies serves hospitals and healthcare systems across the United States.